Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency
{{output}}
Prostate cancer is a disease with heterogeneous characteristics, making its treatability and curability dependent on the cancer's stage. While prostate cancer is often indolent, some cases can be aggressive and evolve into metastatic castration-resistant prost... ...
